Clinical and laboratory characteristics of psoriatic arthritis in a cohort of Egyptian patients

作者: Adel M.A. Elsayed , Noran O. El-Azizi , Dalia A. ElSherbiny , Rofida A. Ghalwash

DOI: 10.1016/J.EJR.2021.03.003

关键词:

摘要: Abstract Aim of the work To detect clinical and laboratory characteristics psoriatic arthritis (PsA) in sample Egyptian population. Patients methods 100 PsA patients were subjected to full medical history, clinical, musculoskeletal dermatological examination, routine investigations assessment disease severity. Results Among patients, 79 females 21 males. The mean age was 44.4 ± 12.9 years. 21% had hypertension, 11% diabetes 4% hepatitis C-virus. 14% family history other rheumatologic disease. 66% experienced psoriasis onset with latency; 11.6 ± 8.2 years, 20% dual both diseases 10% PsA first latency 3.6 ± 3.5 years. 86% enthesitis, 41% dactylitis, 39% axial affection 18% uveitis. 90% current 89% them nail lesion. most common drug methotrexate. 38% spondyloarthritis, 33% symmetric polyarthritis, 26% asymmetric oligoarthritis, 3% predominant distal inter-phalangeal (DIP) involvement. value for serum hemoglobin 12.1 ± 8.21.6 g/dl, platelets; 278.4 ± 90.3 x103/mm3, white blood cells 7.2 ± 2.2 C-reactive protein 10.9 ± 10.1 mg/dl erythrocyte sedimentation rate 49.3 ± 27.5 mm/1st hr. 92% negative rheumatoid factor. Conclusion cohort followed by polyarthritis oligoarthritis. least frequent DIP precedes methotrexate therapy.

参考文章(38)
Pedro Machado, Victoria Navarro‐Compán, Robert Landewé, Floris A. Gaalen, Christian Roux, Désirée Heijde, Calculating the ankylosing spondylitis disease activity score if the conventional c-reactive protein level is below the limit of detection or if high-sensitivity c-reactive protein is used: an analysis in the DESIR cohort. Arthritis & Rheumatism. ,vol. 67, pp. 408- 413 ,(2015) , 10.1002/ART.38921
Amy S. Kehl, Maripat Corr, Michael H. Weisman, Review: Enthesitis: New Insights Into Pathogenesis, Diagnostic Modalities, and Treatment. Arthritis & Rheumatism. ,vol. 68, pp. 312- 322 ,(2016) , 10.1002/ART.39458
Alexis Ogdie, Pamela Weiss, The Epidemiology of Psoriatic Arthritis Rheumatic Diseases Clinics of North America. ,vol. 41, pp. 545- 568 ,(2015) , 10.1016/J.RDC.2015.07.001
Dafna D. Gladman, Olga Ziouzina, Arane Thavaneswaran, Vinod Chandran, Dactylitis in Psoriatic Arthritis: Prevalence and Response to Therapy in the Biologic Era The Journal of Rheumatology. ,vol. 40, pp. 1357- 1359 ,(2013) , 10.3899/JRHEUM.130163
Janice A. Husted, Arane Thavaneswaran, Vinod Chandran, Lihi Eder, Cheryl F. Rosen, Richard J. Cook, Dafna D. Gladman, Cardiovascular and other comorbidities in patients with psoriatic arthritis: A comparison with patients with psoriasis Arthritis Care and Research. ,vol. 63, pp. 1729- 1735 ,(2011) , 10.1002/ACR.20627
Soha Eldessouki Ibrahim, Amir Helmi, Tarek M. Yousef, Mohammad Sobhi Hassan, Naglaa Farouk, Association of asymptomatic hyperuricemia and endothelial dysfunction in psoriatic arthritis The Egyptian Rheumatologist. ,vol. 34, pp. 83- 89 ,(2012) , 10.1016/J.EJR.2012.03.002
Richard G. Langley, Charles N. Ellis, Evaluating psoriasis with Psoriasis Area and Severity Index, Psoriasis Global Assessment, and Lattice System Physician's Global Assessment Journal of The American Academy of Dermatology. ,vol. 51, pp. 563- 569 ,(2004) , 10.1016/J.JAAD.2004.04.012
O. Elkayam, J. Ophir, M. Yaron, D. Caspi, Psoriatic Arthritis: Interrelationships between Skin and Joint Manifestations Related to Onset, Course and Distribution Clinical Rheumatology. ,vol. 19, pp. 301- 305 ,(2000) , 10.1007/PL00011173
C. Ferrandiz, G. Girolomoni, R. Gniadecki, L. Iversen, A. Menter, K. Michaelis-Wittern, A. Morita, H. Nakagawa, K. Reich, M. Augustin, C. Blome, A. Costanzo, E. Dauden, Nail Assessment in Psoriasis and Psoriatic Arthritis (NAPPA): development and validation of a tool for assessment of nail psoriasis outcomes. British Journal of Dermatology. ,vol. 170, pp. 591- 598 ,(2014) , 10.1111/BJD.12664